OClawVPS.com
BioSpace
Edit

BioSpace

http://www.biospace.com/
Last activity: 24.03.2026
Active
Categories: BioTechHomeIndustryLifeMediaMedtechNewsResearchWebsite
Your source for biopharma news and jobs
Likes
61.08K
Website visits
708.3K /mo.
Mentions
1.08K
Location: United States, Iowa, Des Moines
Employees: 11-50
Phone: +1 877-277-7585
Founded date: 1985

Investors 1

DateNameWebsite
25.04.2025Cobro Vent...cobroventu...

Mentions in press and media 1081

DateTitleDescription
24.03.2026Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES StudyDeveloping solutions to improve quality of life after menopause Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization Suffering with vaginal dryness and sexual pain is completely unnecessary. With th...
16.03.2026Конвейер деторождения, мозг мыши за штурвалом и другие новости с переднего края биотехаПриветствую, читатели! Это свежие заметки о жизни на пороге сингулярности. Меня зовут Игорь Santry, я техноредактор. Я завёл эту колонку, чтобы собрать лучшие лонгриды и видео, которые зацепили меня за последнее время. Этот выпуск тематичес...
10.01.20262026 is the year of obesity pills. Here’s how they could reshape the GLP-1 marketIn 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today’s blockbuster injections that could attract entirely new patient...
29.12.2025Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" TherapyTAIPEI and SAN DIEGO, Dec. 29, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging...
15.12.2025Нобелевская премия-2025: кто главные бенефициары научных открытий ученых-лауреатов?Нобелевскую премию вручают за самые передовые открытия — и, конечно, у них есть большой коммерческий потенциал. Право авторства и право на саму разработку — это несколько разные вещи, и возможность получить действительно высокую прибыль буд...
01.12.2025Protego plans pivotal trial for AL amyloidosis prospect with $130M series BProtego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new $130 million series B fundraise. The oversubscribed funding round, led by Novartis Venture Fund and Forbion, picke...
25.08.2025Exclusive: Safe, Direct-to-Brain Autologous Stem Cell Therapy Shows Promise in Alzheimer’sA Phase 1, "first-in-mankind" trial of stem cells injected directly into the brain, is safe with early signs of efficacy; FDA submission made for Phase 2 trial. NEWPORT BEACH, CA, UNITED STATES, August 25, 2025 /EINPresswire.com/ ...
07.08.2025US NCI Sponsors Senhwa Biosciences' Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant LymphomaTAIPEI and SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that US N...
18.07.2025Vested interests. Influence muscle. At RFK Jr.’s HHS, it’s not pharma. It’s wellnessThe total doesn’t include revenue from speaking fees, the sale of wellness products, or other income sources for which data isn’t publicly available. The Means siblings have launched wellness companies that have raised more than $99 million...
16.07.2025Chronic Pain Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and ForecastChronic Pain Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detailed analysis of the current chronic pain marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 1...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In